Credit Suisse Ag Maravai Lifesciences Holdings, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 120,555 shares of MRVI stock, worth $438,820. This represents 0.0% of its overall portfolio holdings.

Number of Shares

120,555

Previous 120,555 -0.0%

Holding current value

$438,820

Previous $789,000 32.45%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$4.7 - $9.87 $38,525 - $80,904	8,197 Added 7.3%	120,555 $789,000
Q3 2023 Nov 13, 2023	SELL	$9.14 - $12.85 $36,468 - $51,271	-3,990 Reduced 3.43%	112,358 $1.12 Million
Q2 2023 Aug 11, 2023	BUY	$12.09 - $15.0 $50,270 - $62,370	4,158 Added 3.71%	116,348 $1.45 Million
Q1 2023 May 10, 2023	BUY	$12.99 - $16.48 $51,843 - $65,771	3,991 Added 3.69%	112,190 $1.57 Million
Q4 2022 Feb 13, 2023	SELL	$12.5 - $24.78 $14,775 - $29,289	-1,182 Reduced 1.08%	108,199 $1.55 Million

Q3 2022 Nov 10, 2022	BUY	$20.6 - $30.37 $65,528 - $96,606	3,181 Added 3.0%	109,381 $2.79 Million
Q2 2022 Aug 12, 2022	SELL	$26.05 - $37.48 $955,592 - $1.37 Million	-36,683 Reduced 25.67%	106,200 $3.02 Million
Q1 2022 May 16, 2022	BUY	$24.46 - $40.92 $1.16 Million - $1.93 Million	47,223 Added 49.37%	142,883 $5.04 Million
Q4 2021 Feb 14, 2022	SELL	$35.0 - $45.94 $4.98 Million - $6.54 Million	-142,350 Reduced 59.81%	95,660 $4.01 Million
Q3 2021 Nov 12, 2021	BUY	$36.8 - $60.62 $6.32 Million - $10.4 Million	171,725 Added 259.07%	238,010 $11.7 Million
Q2 2021 Aug 16, 2021	BUY	$32.46 - $45.0 $2.15 Million - $2.98 Million	66,285 New	66,285 $2.77 Million

Others Institutions Holding MRVI

# of Institutions

182

Shares Held

132M

Call Options Held

688K

Put Options Held

11.6K

View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $479M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

More about MRVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account